U.S. Stem Cell Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
96.10
2,055.80
2,191.20
3,083.30
5,520.50
6,700.90
Cost of Goods Sold (COGS) incl. D&A
33.00
849.40
978.30
977.80
1,891.90
2,111.10
Gross Income
63.10
1,206.40
1,212.90
2,105.50
3,628.60
4,589.80
SG&A Expense
2,894.80
4,735.90
3,758.80
3,265.00
4,433.30
5,687.70
EBIT
2,831.80
3,529.50
2,545.90
1,159.60
804.70
1,097.90
Unusual Expense
1,052.60
2,924.60
2,575.50
109.90
2,334.50
5.60
Non Operating Income/Expense
73.80
9.10
13.30
11.50
107.40
128.80
Interest Expense
1,437.90
1,639.60
1,723.30
1,185.60
642.10
1,444.80
Pretax Income
3,143.30
2,253.50
1,641.90
2,070.40
3,481.50
2,160.40
Consolidated Net Income
3,143.30
2,253.50
1,641.90
2,070.40
3,481.50
2,160.40
Net Income
3,143.30
2,253.50
1,641.90
2,070.40
3,481.50
2,160.40
Net Income After Extraordinaries
3,143.30
2,253.50
1,641.90
2,070.40
3,481.50
2,160.40
Net Income Available to Common
3,143.30
2,253.50
1,641.90
2,070.40
3,481.50
2,160.40
EPS (Basic)
12.48
4.61
1.80
0.09
0.01
0.01
Basic Shares Outstanding
251.80
488.70
912.10
24,151.00
309,009.90
365,636.50
EPS (Diluted)
12.48
4.61
1.80
0.09
0.01
0.01
Diluted Shares Outstanding
251.80
488.70
912.10
24,151.00
309,009.90
365,636.50
EBITDA
2,829.60
3,525.00
2,540.60
1,153.80
625.90
890.80
Equity in Affiliates (Pretax)
-
-
38.50
153.40
192.40
247.80
About U.S. Stem Cell
View Profile
